Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
84,733,230
-
Total 13F shares
-
62,516,525
-
Share change
-
-607,344
-
Total reported value
-
$216,373,636
-
Put/Call ratio
-
41%
-
Price per share
-
$3.46
-
Number of holders
-
130
-
Value change
-
-$1,660,759
-
Number of buys
-
71
-
Number of sells
-
42
Institutional Holders of SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) as of Q3 2024
As of 30 Sep 2024,
SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) was held by
130 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
62,516,525 shares.
The largest 10 holders included
SUVRETTA CAPITAL MANAGEMENT, LLC, BlackRock, Inc., VANGUARD GROUP INC, Point72 Asset Management, L.P., MPM BIOIMPACT LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Samsara BioCapital, LLC, CITADEL ADVISORS LLC, Kynam Capital Management, LP, and MILLENNIUM MANAGEMENT LLC.
This page lists
130
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.